Selected research
Industry Research
Custom Synthesis and Radiolabeling Industry Research Report 2026
Market perspective
The global Custom Synthesis and Radiolabeling market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Synthesis and Radiolabeling market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Synthesis and Radiolabeling market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Synthesis and Radiolabeling market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Synthesis and Radiolabeling include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Synthesis and Radiolabeling market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Synthesis and Radiolabeling.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Synthesis and Radiolabeling Market by Company
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology
Custom Synthesis and Radiolabeling Segment by Type
C-14
H-3
I-125
Others
Custom Synthesis and Radiolabeling Segment by Application
Drug Discovery
Medical
Others
Custom Synthesis and Radiolabeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Synthesis and Radiolabeling companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Custom Synthesis and Radiolabeling Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2021-2026)
Table 7. Global Custom Synthesis and Radiolabeling Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2027-2032)
Table 9. Global Custom Synthesis and Radiolabeling Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2021-2026)
Table 11. Global Custom Synthesis and Radiolabeling Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2027-2032)
Table 13. Global Custom Synthesis and Radiolabeling Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Custom Synthesis and Radiolabeling Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Custom Synthesis and Radiolabeling Market Share by Region (2021-2026)
Table 16. Global Custom Synthesis and Radiolabeling Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Custom Synthesis and Radiolabeling Market Share by Region (2027-2032)
Table 18. Custom Synthesis and Radiolabeling Industry Trends
Table 19. Custom Synthesis and Radiolabeling Industry Drivers
Table 20. Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
Table 21. Custom Synthesis and Radiolabeling Market Restraints
Table 22. Global Top Custom Synthesis and Radiolabeling Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Custom Synthesis and Radiolabeling Revenue Market Share by Players (2021-2026)
Table 24. Global Custom Synthesis and Radiolabeling Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Custom Synthesis and Radiolabeling, Headquarters and Area Served
Table 26. Global Custom Synthesis and Radiolabeling Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Custom Synthesis and Radiolabeling by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Custom Synthesis and Radiolabeling Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Custom Synthesis and Radiolabeling Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Custom Synthesis and Radiolabeling Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Custom Synthesis and Radiolabeling Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Custom Synthesis and Radiolabeling Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Custom Synthesis and Radiolabeling Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Custom Synthesis and Radiolabeling Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Custom Synthesis and Radiolabeling Market Size by Country (2027-2032) & (US$ Million)
Table 45. Charles River Company Information
Table 46. Charles River Business Overview
Table 47. Charles River Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 48. Charles River Custom Synthesis and Radiolabeling Product Portfolio
Table 49. Charles River Recent Developments
Table 50. Eurofins Scientific Company Information
Table 51. Eurofins Scientific Business Overview
Table 52. Eurofins Scientific Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 53. Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
Table 54. Eurofins Scientific Recent Developments
Table 55. PerkinElmer Company Information
Table 56. PerkinElmer Business Overview
Table 57. PerkinElmer Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 58. PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
Table 59. PerkinElmer Recent Developments
Table 60. Sekisui Medical Company Information
Table 61. Sekisui Medical Business Overview
Table 62. Sekisui Medical Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 63. Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
Table 64. Sekisui Medical Recent Developments
Table 65. Eckert & Ziegler Company Information
Table 66. Eckert & Ziegler Business Overview
Table 67. Eckert & Ziegler Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 68. Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
Table 69. Eckert & Ziegler Recent Developments
Table 70. Labcorp Company Information
Table 71. Labcorp Business Overview
Table 72. Labcorp Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 73. Labcorp Custom Synthesis and Radiolabeling Product Portfolio
Table 74. Labcorp Recent Developments
Table 75. XenoTech (BioIVT) Company Information
Table 76. XenoTech (BioIVT) Business Overview
Table 77. XenoTech (BioIVT) Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 78. XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
Table 79. XenoTech (BioIVT) Recent Developments
Table 80. Quotient Sciences Company Information
Table 81. Quotient Sciences Business Overview
Table 82. Quotient Sciences Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 83. Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
Table 84. Quotient Sciences Recent Developments
Table 85. Gifford Bioscience Company Information
Table 86. Gifford Bioscience Business Overview
Table 87. Gifford Bioscience Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 88. Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
Table 89. Gifford Bioscience Recent Developments
Table 90. ITM Radiopharma Company Information
Table 91. ITM Radiopharma Business Overview
Table 92. ITM Radiopharma Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 93. ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
Table 94. ITM Radiopharma Recent Developments
Table 95. Almac Group Company Information
Table 96. Almac Group Business Overview
Table 97. Almac Group Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 98. Almac Group Custom Synthesis and Radiolabeling Product Portfolio
Table 99. Almac Group Recent Developments
Table 100. Accelera Company Information
Table 101. Accelera Business Overview
Table 102. Accelera Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 103. Accelera Custom Synthesis and Radiolabeling Product Portfolio
Table 104. Accelera Recent Developments
Table 105. Novandi Chemistry Company Information
Table 106. Novandi Chemistry Business Overview
Table 107. Novandi Chemistry Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 108. Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
Table 109. Novandi Chemistry Recent Developments
Table 110. AptoChem Company Information
Table 111. AptoChem Business Overview
Table 112. AptoChem Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 113. AptoChem Custom Synthesis and Radiolabeling Product Portfolio
Table 114. AptoChem Recent Developments
Table 115. HMR Company Information
Table 116. HMR Business Overview
Table 117. HMR Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 118. HMR Custom Synthesis and Radiolabeling Product Portfolio
Table 119. HMR Recent Developments
Table 120. AM Chemicals Company Information
Table 121. AM Chemicals Business Overview
Table 122. AM Chemicals Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 123. AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
Table 124. AM Chemicals Recent Developments
Table 125. PolyPeptide Group Company Information
Table 126. PolyPeptide Group Business Overview
Table 127. PolyPeptide Group Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 128. PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
Table 129. PolyPeptide Group Recent Developments
Table 130. NovoPro Bioscience Company Information
Table 131. NovoPro Bioscience Business Overview
Table 132. NovoPro Bioscience Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 133. NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
Table 134. NovoPro Bioscience Recent Developments
Table 135. Institute of Isotopes Company Information
Table 136. Institute of Isotopes Business Overview
Table 137. Institute of Isotopes Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 138. Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
Table 139. Institute of Isotopes Recent Developments
Table 140. Nuvisan Company Information
Table 141. Nuvisan Business Overview
Table 142. Nuvisan Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 143. Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
Table 144. Nuvisan Recent Developments
Table 145. Revvity Company Information
Table 146. Revvity Business Overview
Table 147. Revvity Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 148. Revvity Custom Synthesis and Radiolabeling Product Portfolio
Table 149. Revvity Recent Developments
Table 150. Necsa Company Information
Table 151. Necsa Business Overview
Table 152. Necsa Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 153. Necsa Custom Synthesis and Radiolabeling Product Portfolio
Table 154. Necsa Recent Developments
Table 155. Fluorizon Company Information
Table 156. Fluorizon Business Overview
Table 157. Fluorizon Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 158. Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
Table 159. Fluorizon Recent Developments
Table 160. Edinburgh Pharmaceutical Processes Company Information
Table 161. Edinburgh Pharmaceutical Processes Business Overview
Table 162. Edinburgh Pharmaceutical Processes Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 163. Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
Table 164. Edinburgh Pharmaceutical Processes Recent Developments
Table 165. Chelatec Company Information
Table 166. Chelatec Business Overview
Table 167. Chelatec Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 168. Chelatec Custom Synthesis and Radiolabeling Product Portfolio
Table 169. Chelatec Recent Developments
Table 170. Pharmaron Company Information
Table 171. Pharmaron Business Overview
Table 172. Pharmaron Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 173. Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
Table 174. Pharmaron Recent Developments
Table 175. Medicilon Company Information
Table 176. Medicilon Business Overview
Table 177. Medicilon Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 178. Medicilon Custom Synthesis and Radiolabeling Product Portfolio
Table 179. Medicilon Recent Developments
Table 180. JOINN Laboratories Company Information
Table 181. JOINN Laboratories Business Overview
Table 182. JOINN Laboratories Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 183. JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
Table 184. JOINN Laboratories Recent Developments
Table 185. Frontage Company Information
Table 186. Frontage Business Overview
Table 187. Frontage Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 188. Frontage Custom Synthesis and Radiolabeling Product Portfolio
Table 189. Frontage Recent Developments
Table 190. Abace Biotechnology Company Information
Table 191. Abace Biotechnology Business Overview
Table 192. Abace Biotechnology Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 193. Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
Table 194. Abace Biotechnology Recent Developments
Table 195. Beijing Atom High-Tech Company Information
Table 196. Beijing Atom High-Tech Business Overview
Table 197. Beijing Atom High-Tech Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 198. Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
Table 199. Beijing Atom High-Tech Recent Developments
Table 200. Wuxi Beita Pharmatech Company Information
Table 201. Wuxi Beita Pharmatech Business Overview
Table 202. Wuxi Beita Pharmatech Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 203. Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
Table 204. Wuxi Beita Pharmatech Recent Developments
Table 205. Beijing North Institute of Biotechnology Company Information
Table 206. Beijing North Institute of Biotechnology Business Overview
Table 207. Beijing North Institute of Biotechnology Revenue in Custom Synthesis and Radiolabeling Business (2021-2026) & (US$ Million)
Table 208. Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
Table 209. Beijing North Institute of Biotechnology Recent Developments
Table 210. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Custom Synthesis and Radiolabeling Product Image
Figure 5. Global Custom Synthesis and Radiolabeling Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Custom Synthesis and Radiolabeling Market Share by Type: 2025 VS 2032
Figure 7. C-14 Product
Figure 8. H-3 Product
Figure 9. I-125 Product
Figure 10. Others Product
Figure 11. Global Custom Synthesis and Radiolabeling Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Custom Synthesis and Radiolabeling Market Share by Application: 2025 VS 2032
Figure 13. Drug Discovery Product
Figure 14. Medical Product
Figure 15. Others Product
Figure 16. Global Custom Synthesis and Radiolabeling Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Custom Synthesis and Radiolabeling Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Custom Synthesis and Radiolabeling Market Share by Region: 2025 VS 2032
Figure 19. Global Custom Synthesis and Radiolabeling Market Share by Players in 2025
Figure 20. Global Custom Synthesis and Radiolabeling Manufacturers Established Date
Figure 21. Global Top 5 and 10 Custom Synthesis and Radiolabeling Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 25. United States Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 28. Europe Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 30. Germany Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 40. China Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 45. Australia Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Custom Synthesis and Radiolabeling Market Share by Country (2021-2032)
Figure 50. Brazil Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Custom Synthesis and Radiolabeling Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Charles River Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 56. Eurofins Scientific Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 57. PerkinElmer Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 58. Sekisui Medical Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 59. Eckert & Ziegler Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 60. Labcorp Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 61. XenoTech (BioIVT) Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 62. Quotient Sciences Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 63. Gifford Bioscience Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 64. ITM Radiopharma Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 65. Almac Group Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 66. Accelera Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 67. Novandi Chemistry Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 68. AptoChem Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 69. HMR Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 70. AM Chemicals Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 71. PolyPeptide Group Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 72. NovoPro Bioscience Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 73. Institute of Isotopes Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 74. Nuvisan Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 75. Revvity Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 76. Necsa Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 77. Fluorizon Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 78. Edinburgh Pharmaceutical Processes Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 79. Chelatec Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 80. Pharmaron Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 81. Medicilon Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 82. JOINN Laboratories Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 83. Frontage Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 84. Abace Biotechnology Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 85. Beijing Atom High-Tech Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 86. Wuxi Beita Pharmatech Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Figure 87. Beijing North Institute of Biotechnology Revenue Growth Rate in Custom Synthesis and Radiolabeling Business (2021-2026)
Scope & coverage.
Types
- C-14
- H-3
- I-125
- Others
Applications
- Drug Discovery
- Medical
- Others
Companies covered
- Charles River
- Eurofins Scientific
- PerkinElmer
- Sekisui Medical
- Eckert & Ziegler
- Labcorp
- XenoTech (BioIVT)
- Quotient Sciences
- Gifford Bioscience
- ITM Radiopharma
- Almac Group
- Accelera
- Novandi Chemistry
- AptoChem
- HMR
- AM Chemicals
- PolyPeptide Group
- NovoPro Bioscience
- Institute of Isotopes
- Nuvisan
- Revvity
- Necsa
- Fluorizon
- Edinburgh Pharmaceutical Processes
- Chelatec
- Pharmaron
- Medicilon
- JOINN Laboratories
- Frontage
- Abace Biotechnology
- Beijing Atom High-Tech
- Wuxi Beita Pharmatech
- Beijing North Institute of Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Synthesis and Radiolabeling by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 C-14
- 2.2.3 H-3
- 2.2.4 I-125
- 2.2.5 Others
- 2.3 Custom Synthesis and Radiolabeling by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Medical
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Custom Synthesis and Radiolabeling Breakdown Data by Type
- 3.1 Global Custom Synthesis and Radiolabeling Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Synthesis and Radiolabeling Forecasted Market Size by Type (2027-2032)
4 Custom Synthesis and Radiolabeling Breakdown Data by Application
- 4.1 Global Custom Synthesis and Radiolabeling Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Synthesis and Radiolabeling Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Synthesis and Radiolabeling Market Perspective (2021-2032)
- 5.2 Global Custom Synthesis and Radiolabeling Growth Trends by Region
- 5.2.1 Global Custom Synthesis and Radiolabeling Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Synthesis and Radiolabeling Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Synthesis and Radiolabeling Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Synthesis and Radiolabeling Market Dynamics
- 5.3.1 Custom Synthesis and Radiolabeling Industry Trends
- 5.3.2 Custom Synthesis and Radiolabeling Market Drivers
- 5.3.3 Custom Synthesis and Radiolabeling Market Challenges
- 5.3.4 Custom Synthesis and Radiolabeling Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Synthesis and Radiolabeling Players by Revenue
- 6.1.1 Global Top Custom Synthesis and Radiolabeling Players by Revenue (2021-2026)
- 6.1.2 Global Custom Synthesis and Radiolabeling Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Synthesis and Radiolabeling Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Synthesis and Radiolabeling Head Office and Area Served
- 6.4 Global Custom Synthesis and Radiolabeling Players, Product Type & Application
- 6.5 Global Custom Synthesis and Radiolabeling Manufacturers Established Date
- 6.6 Global Custom Synthesis and Radiolabeling Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 7.2 North America Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 7.4 North America Custom Synthesis and Radiolabeling Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 8.2 Europe Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 8.4 Europe Custom Synthesis and Radiolabeling Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Synthesis and Radiolabeling Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 10.2 South America Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 10.4 South America Custom Synthesis and Radiolabeling Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Synthesis and Radiolabeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Synthesis and Radiolabeling Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.1.4 Charles River Custom Synthesis and Radiolabeling Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 Eurofins Scientific
- 12.2.1 Eurofins Scientific Company Information
- 12.2.2 Eurofins Scientific Business Overview
- 12.2.3 Eurofins Scientific Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.2.4 Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
- 12.2.5 Eurofins Scientific Recent Developments
- 12.3 PerkinElmer
- 12.3.1 PerkinElmer Company Information
- 12.3.2 PerkinElmer Business Overview
- 12.3.3 PerkinElmer Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.3.4 PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
- 12.3.5 PerkinElmer Recent Developments
- 12.4 Sekisui Medical
- 12.4.1 Sekisui Medical Company Information
- 12.4.2 Sekisui Medical Business Overview
- 12.4.3 Sekisui Medical Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.4.4 Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
- 12.4.5 Sekisui Medical Recent Developments
- 12.5 Eckert & Ziegler
- 12.5.1 Eckert & Ziegler Company Information
- 12.5.2 Eckert & Ziegler Business Overview
- 12.5.3 Eckert & Ziegler Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.5.4 Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
- 12.5.5 Eckert & Ziegler Recent Developments
- 12.6 Labcorp
- 12.6.1 Labcorp Company Information
- 12.6.2 Labcorp Business Overview
- 12.6.3 Labcorp Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.6.4 Labcorp Custom Synthesis and Radiolabeling Product Portfolio
- 12.6.5 Labcorp Recent Developments
- 12.7 XenoTech (BioIVT)
- 12.7.1 XenoTech (BioIVT) Company Information
- 12.7.2 XenoTech (BioIVT) Business Overview
- 12.7.3 XenoTech (BioIVT) Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.7.4 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
- 12.7.5 XenoTech (BioIVT) Recent Developments
- 12.8 Quotient Sciences
- 12.8.1 Quotient Sciences Company Information
- 12.8.2 Quotient Sciences Business Overview
- 12.8.3 Quotient Sciences Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.8.4 Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
- 12.8.5 Quotient Sciences Recent Developments
- 12.9 Gifford Bioscience
- 12.9.1 Gifford Bioscience Company Information
- 12.9.2 Gifford Bioscience Business Overview
- 12.9.3 Gifford Bioscience Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.9.4 Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 12.9.5 Gifford Bioscience Recent Developments
- 12.10 ITM Radiopharma
- 12.10.1 ITM Radiopharma Company Information
- 12.10.2 ITM Radiopharma Business Overview
- 12.10.3 ITM Radiopharma Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.10.4 ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
- 12.10.5 ITM Radiopharma Recent Developments
- 12.11 Almac Group
- 12.11.1 Almac Group Company Information
- 12.11.2 Almac Group Business Overview
- 12.11.3 Almac Group Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.11.4 Almac Group Custom Synthesis and Radiolabeling Product Portfolio
- 12.11.5 Almac Group Recent Developments
- 12.12 Accelera
- 12.12.1 Accelera Company Information
- 12.12.2 Accelera Business Overview
- 12.12.3 Accelera Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.12.4 Accelera Custom Synthesis and Radiolabeling Product Portfolio
- 12.12.5 Accelera Recent Developments
- 12.13 Novandi Chemistry
- 12.13.1 Novandi Chemistry Company Information
- 12.13.2 Novandi Chemistry Business Overview
- 12.13.3 Novandi Chemistry Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.13.4 Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
- 12.13.5 Novandi Chemistry Recent Developments
- 12.14 AptoChem
- 12.14.1 AptoChem Company Information
- 12.14.2 AptoChem Business Overview
- 12.14.3 AptoChem Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.14.4 AptoChem Custom Synthesis and Radiolabeling Product Portfolio
- 12.14.5 AptoChem Recent Developments
- 12.15 HMR
- 12.15.1 HMR Company Information
- 12.15.2 HMR Business Overview
- 12.15.3 HMR Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.15.4 HMR Custom Synthesis and Radiolabeling Product Portfolio
- 12.15.5 HMR Recent Developments
- 12.16 AM Chemicals
- 12.16.1 AM Chemicals Company Information
- 12.16.2 AM Chemicals Business Overview
- 12.16.3 AM Chemicals Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.16.4 AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
- 12.16.5 AM Chemicals Recent Developments
- 12.17 PolyPeptide Group
- 12.17.1 PolyPeptide Group Company Information
- 12.17.2 PolyPeptide Group Business Overview
- 12.17.3 PolyPeptide Group Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.17.4 PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
- 12.17.5 PolyPeptide Group Recent Developments
- 12.18 NovoPro Bioscience
- 12.18.1 NovoPro Bioscience Company Information
- 12.18.2 NovoPro Bioscience Business Overview
- 12.18.3 NovoPro Bioscience Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.18.4 NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 12.18.5 NovoPro Bioscience Recent Developments
- 12.19 Institute of Isotopes
- 12.19.1 Institute of Isotopes Company Information
- 12.19.2 Institute of Isotopes Business Overview
- 12.19.3 Institute of Isotopes Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.19.4 Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
- 12.19.5 Institute of Isotopes Recent Developments
- 12.20 Nuvisan
- 12.20.1 Nuvisan Company Information
- 12.20.2 Nuvisan Business Overview
- 12.20.3 Nuvisan Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.20.4 Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
- 12.20.5 Nuvisan Recent Developments
- 12.21 Revvity
- 12.21.1 Revvity Company Information
- 12.21.2 Revvity Business Overview
- 12.21.3 Revvity Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.21.4 Revvity Custom Synthesis and Radiolabeling Product Portfolio
- 12.21.5 Revvity Recent Developments
- 12.22 Necsa
- 12.22.1 Necsa Company Information
- 12.22.2 Necsa Business Overview
- 12.22.3 Necsa Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.22.4 Necsa Custom Synthesis and Radiolabeling Product Portfolio
- 12.22.5 Necsa Recent Developments
- 12.23 Fluorizon
- 12.23.1 Fluorizon Company Information
- 12.23.2 Fluorizon Business Overview
- 12.23.3 Fluorizon Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.23.4 Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
- 12.23.5 Fluorizon Recent Developments
- 12.24 Edinburgh Pharmaceutical Processes
- 12.24.1 Edinburgh Pharmaceutical Processes Company Information
- 12.24.2 Edinburgh Pharmaceutical Processes Business Overview
- 12.24.3 Edinburgh Pharmaceutical Processes Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.24.4 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
- 12.24.5 Edinburgh Pharmaceutical Processes Recent Developments
- 12.25 Chelatec
- 12.25.1 Chelatec Company Information
- 12.25.2 Chelatec Business Overview
- 12.25.3 Chelatec Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.25.4 Chelatec Custom Synthesis and Radiolabeling Product Portfolio
- 12.25.5 Chelatec Recent Developments
- 12.26 Pharmaron
- 12.26.1 Pharmaron Company Information
- 12.26.2 Pharmaron Business Overview
- 12.26.3 Pharmaron Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.26.4 Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
- 12.26.5 Pharmaron Recent Developments
- 12.27 Medicilon
- 12.27.1 Medicilon Company Information
- 12.27.2 Medicilon Business Overview
- 12.27.3 Medicilon Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.27.4 Medicilon Custom Synthesis and Radiolabeling Product Portfolio
- 12.27.5 Medicilon Recent Developments
- 12.28 JOINN Laboratories
- 12.28.1 JOINN Laboratories Company Information
- 12.28.2 JOINN Laboratories Business Overview
- 12.28.3 JOINN Laboratories Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.28.4 JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
- 12.28.5 JOINN Laboratories Recent Developments
- 12.29 Frontage
- 12.29.1 Frontage Company Information
- 12.29.2 Frontage Business Overview
- 12.29.3 Frontage Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.29.4 Frontage Custom Synthesis and Radiolabeling Product Portfolio
- 12.29.5 Frontage Recent Developments
- 12.30 Abace Biotechnology
- 12.30.1 Abace Biotechnology Company Information
- 12.30.2 Abace Biotechnology Business Overview
- 12.30.3 Abace Biotechnology Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.30.4 Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 12.30.5 Abace Biotechnology Recent Developments
- 12.31 Beijing Atom High-Tech
- 12.31.1 Beijing Atom High-Tech Company Information
- 12.31.2 Beijing Atom High-Tech Business Overview
- 12.31.3 Beijing Atom High-Tech Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.31.4 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
- 12.31.5 Beijing Atom High-Tech Recent Developments
- 12.32 Wuxi Beita Pharmatech
- 12.32.1 Wuxi Beita Pharmatech Company Information
- 12.32.2 Wuxi Beita Pharmatech Business Overview
- 12.32.3 Wuxi Beita Pharmatech Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.32.4 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
- 12.32.5 Wuxi Beita Pharmatech Recent Developments
- 12.33 Beijing North Institute of Biotechnology
- 12.33.1 Beijing North Institute of Biotechnology Company Information
- 12.33.2 Beijing North Institute of Biotechnology Business Overview
- 12.33.3 Beijing North Institute of Biotechnology Revenue in Custom Synthesis and Radiolabeling Business (2021-2026)
- 12.33.4 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 12.33.5 Beijing North Institute of Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst